Strategic Team

Strategic Team

Annadurai Dharmarajan, M.Pharm., MBA.
Founder & Chief Scientific Officer.

Annadurai is 20+ years veteran focused on Product Development, Technology transfer and Project management of NDA’s and ANDA’s.
He amassed experience in Life Cycle Management, Paragraph IV and difficult to make product by working with Aventis, Sandoz, Caraco, Paddock Labs and Fera Pharmaceuticals.

Prof. Raj Suryanarayanan (Sury), Ph.D.

Prof. Raj Suryanarayanan (Sury) Ph.D is William and Mildred Peters Endowed Chair in Pharmaceutics in the College of Pharmacy, University of Minnesota.

He has developed X-ray diffractometric techniques for the qualitative and quantitative analyses of solid phases, to determine the drug content in intact tablets and to study solid-state reactions.

His research group is currently involved in developing low temperature powder X-ray diffractometric techniques to study frozen and freeze-dried pharmaceutical systems.
He is a fellow of the AAPS and is the past-chair of the Teachers of Pharmaceutics Section of the American Association of Colleges of Pharmacy.

In 2010, he was the recipient of the Outstanding Educator Award from AAPS recognizing excellence in education in the technologies related to pharmaceuticals.

Vijay Tammara, Ph.D.

Dr. Tammara has 20 years of Leadership experience in regulatory/Strategic Clinical Development/Biopharmaceutics.

Dr.Tammara also worked at Merck, Wyeth as well as at Sanofi Aventis.
Prior to his industry positions, Dr. Tammara held positions of increasing responsibility including Team Leader in the Office of Clinical Pharmacology and Biopharmaceutics at the FDA.

He has received several FDA awards including the CDER Outstanding Reviewer Award.

Sanjay Nimkar, Ph.D.
V.P. Regulatory

Dr. Nimkar has 20 years of experience in pharmaceutical research and development of which over 10 years in regulatory affairs.
He has experience working in contract research organizations (CROs) and also in major pharmaceutical companies.
He was involved in design, development and preparation of several regulatory submissions up to NDA and ANDA including all related submissions.
Dr. Nimkar received Ph.D. in organic chemistry from Emory University, Atlanta, GA.

About Dharma Labs

Dharma Laboratories is global provider of product development services and has experience in developing Branded and Generic Product. We have



Product Development We have extensive Product development expertise in Branded and generic product with  decades of drug pre-formulati



Formulation Development Formulation Development for NCE Products Novel formulations for improved delivery of existing dosage forms 505


Our Values

At Dharma Labs, our value is to put our customer first